Literature DB >> 975814

Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel.

E Weiner, E D Johansson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 975814     DOI: 10.1016/s0010-7824(76)80011-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


× No keyword cloud information.
  7 in total

1.  Facts about an implantable contraceptive: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

2.  [Concerning an implantable contraceptive: a memorandum of a WHO meeting].

Authors: 
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

3.  Development, validation and utilization of a highly sensitive LC-MS/MS method for quantification of levonorgestrel released from a subdermal implant in human plasma.

Authors:  Lauren R Cirrincione; Sujan Dilly Penchala; Kimberly K Scarsi; Anthony T Podany; Lee C Winchester; David J Back; Saye H Khoo; Courtney V Fletcher; Marco Siccardi; Laura J Else
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-03-12       Impact factor: 3.205

Review 4.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

5.  Malignant neoplasms of decidual origin (deciduosarcomas) induced by estrogen-progestin-releasing intravaginal devices in rabbits.

Authors:  B C Zook; I Spiro; R Hertz
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

6.  Oral contraceptive administration, interfemale relationships, and sexual behavior in Macaca fascicularis.

Authors:  C A Shively; S B Manuck; J R Kaplan; D R Koritnik
Journal:  Arch Sex Behav       Date:  1990-04

Review 7.  Levonorgestrel. Clinical pharmacokinetics.

Authors:  K Fotherby
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.